Skip to main content
. 2018 Jul 19;9(4):465–492. doi: 10.1093/advances/nmy025

TABLE 2.

Half-lives of xanthophylls in serum depletion and supplementation studies1

Intervention/study design and carotenoid Number of participants (health, sex) Age, y Study duration, wk Food/agent (carotenoid dose × duration) Cmax, µmol/L T 1/2, d Year (ref)
Controlled low-carotenoid diet during controlled low-carotenoid diet 12 (healthy men) 25–43 13 ≤0.4 mg total carotenoids/d × 13 wk 1992 (26)
 Lutein/zeaxanthin 0.28 ± 0.052 33–613
 β-Cryptoxanthin 0.22 ± 0.042 ≤123
Serum carotenoid depletion during controlled low-carotenoid diet 19 (healthy women) 18–42 10 0.07 mg total carotenoids/d × 10 wk 2001 (21)
 Lutein L/Z: 0.44 ± 0.042 76 ± 172
 Zeaxanthin 38 ± 72
 β-Cryptoxanthin 0.31 ± 0.052 39 ± 42
Serum carotenoid depletion 2002 (27)
 Lutein 10 (T1D, both) 24 ± 6 3 0.05–0.07 mg/d × 3 wk 0.153 (control) ≥153
8 (controls, both) 27 ± 3 3 0.05–0.07 mg/d × 3 wk 0.163 (T1D) ≥153
Daily oral lutein supplement4 19 (healthy, 50% men) 20–35 9 Oral lutein supplement: 4.1 or 20.5 mg/d × 6 wk 4.1 mg/d: 0.4 ± 0.2; 20.5 mg/d: 1.3 ± 0.8 4.1 mg/d: 5.5 ± 2.1; 20.5 mg/d: 6.1 ± 1.0 2005 (28)
Daily oral lutein supplement 2 (healthy men) 42, 51 52 Oral lutein supplement: 30 mg/d × 20 wk 1.85; 3.3 ∼14.56 1997 (29)
13C-Lutein in kale 7 (healthy, both) 46 ± 14 3 (single dose) 13C-Lutein in kale, 19 mg 0.38 ± 0.08 ∼4.66 2005 (30)
14C-Lutein extracted from spinach 1 (healthy women) 45 9 (single dose) 14C-Lutein extracted from spinach, 0.071 mg 0.003 9.85 2005 (31)
1

Values are means ± SDs unless otherwise indicated. Cmax, maximal plasma or serum concentration attained; L/Z, lutein/zeaxanthin; ref, reference; T1/2, plasma or serum half-life; T1D, type 1 diabetes.

2

Mean ± SE.

3

Error term not provided.

4

Supplement contained 8.3% zeaxanthin relative to lutein.

5

One value is provided for each subject.

6

Half-life estimated from published data for this publication.